Yasuhiro Umeyama

Sasebo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer.

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 23, 2025

Thoracoscopic Removal of a Fish Bone Retained in the Lung for Five Years without the Need for Lung Resection: A Case Report.

Thoracoscopic Removal of a Fish Bone Retained in the Lung for Five Years without the Need for Lung Resection: A Case Report.

Journal: Surgical case reports
Published: July 31, 2025

A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.

A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.

Journal: Journal of thoracic disease
Published: May 31, 2025

Successful EGFR Mutation Detection in Cytological Specimens of Lung Cancer with Challenging Biopsies by Integrating Virtual Bronchoscopy Navigation and Endobronchial Ultrasound Guidance with Highly Sensitive Next-Generation Sequencing: A Case Report.

Successful EGFR Mutation Detection in Cytological Specimens of Lung Cancer with Challenging Biopsies by Integrating Virtual Bronchoscopy Navigation and Endobronchial Ultrasound Guidance with Highly Sensitive Next-Generation Sequencing: A Case Report.

Journal: Case reports in oncology
Published: June 28, 2024

Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.

Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.

Journal: Thoracic cancer
Published: August 16, 2023

Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma.

Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma.

Journal: Frontiers in immunology
Published: September 30, 2022

Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy.

Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy.

Journal: Lung cancer management
Published: January 13, 2022

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.

Journal: Journal of clinical medicine
Published: August 04, 2021

Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.

Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.

Journal: Thoracic cancer
Published: April 28, 2021

Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case report.

Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case report.

Journal: Thoracic cancer
Published: January 21, 2021

Trends in Outpatient Chemotherapy for Thoracic Oncology

Trends in Outpatient Chemotherapy for Thoracic Oncology

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 01, 2020

Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.

Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.

Journal: Thoracic cancer
Published: October 08, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026